GSK’s profit rose on better-than-expected performance of HIV, cancer and asthma treatments, offsetting lower vaccine demand ...

Gilead Sciences agreed to pay $202 million to settle a whistleblower lawsuit accusing the drugmaker of civil fraud for paying ...

The settlement, which calls for Gilead to pay the U.S. nearly $177 million and the balance to various states, was approved ...

The Illinois Department of Public Health has issued a standing order that will allow residents to obtain the HIV preventive ...

A panelist discusses how the HIV patient population has aged significantly, with the average age in their clinic now ...

In Zambia, truck drivers and sex workers have high rates of being HIV positive —- and are at high risk of contracting the ...

An ambitious plan to stop the global threat of AIDS has been derailed. But many are hopeful that progress can be salvaged.

The US administration should clear up the confusion over the future of a widely admired AIDS fund and push for Congress to ...

In a first-ever milestone, Africa’s initial HIV cure trial has yielded historic findings: 20% of patients have remained off ...

Among programs slated for elimination are ones disproportionately impacting LBGTQ people, including HIV prevention and ...

Cuts to sexual health clinics could make eliminating new HIV cases in England by 2030 “impossible”, politicians have warned.

Dolutegravir is recommended by the World Health Organization (WHO) for infants, children and adults and is the preferred HIV ...